Skip to main content
Premium Trial:

Request an Annual Quote

Dutch University Gets 4.6M Euro Boost for Genomics Research

GRONINGEN, The Netherlands, Jan 16 - The University of Groningen and the Academic Hospital in Groningen, in The Netherlands, will each invest 2.3 million euros, or roughly $2 million apiece, to help bolster the university's Genomics Centre, the university announced recently.

Both institutions want the center to be one of the main facilities in an upcoming national research program organized by the Nationaal Regieorgaan Genomics, according to the school. Known in English as the National Management Institute of Genomics, the government group will announce its choices on April 1.

The University of Groningen and the Academic Hospital, which announced their investments on Jan. 8, have conducted research together in clinical genomics and microbial genomics for a few years.

The Groningen Genomics Center, led by Lubbert Dijkhuizen, a professor at the university, employs more than 200 genomic scientists. Before the center was created these researchers were scattered in different departments, and the center allows different research efforts to be combined.

The 4.6-million-euro investment will go to support the center and will allow it to employ a greater number of researchers, it said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.